Boston Partners’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-285,530
| Closed | -$971K | – | 773 |
|
|
2018
Q3 | $971K | Sell |
285,530
-7,574
| -3% | -$25.8K | ﹤0.01% | 668 |
|
|
2018
Q2 | $1.1M | Buy |
293,104
+36,544
| +14% | +$137K | ﹤0.01% | 733 |
|
|
2018
Q1 | $1.05M | Sell |
256,560
-152,491
| -37% | -$623K | ﹤0.01% | 694 |
|
|
2017
Q4 | $1.9M | Hold |
409,051
| – | – | ﹤0.01% | 672 |
|
|
2017
Q3 | $2.9M | Hold |
409,051
| – | – | ﹤0.01% | 616 |
|
|
2017
Q2 | $2.96M | Hold |
409,051
| – | – | ﹤0.01% | 596 |
|
|
2017
Q1 | $2.52M | Hold |
409,051
| – | – | ﹤0.01% | 633 |
|
|
2016
Q4 | $2.4M | Hold |
409,051
| – | – | ﹤0.01% | 652 |
|
|
2016
Q3 | $2.17M | Buy |
+409,051
| New | +$2.17M | ﹤0.01% | 651 |
|